Cytovale
PrivateLast Round
Series D
Oct 10, 2024
Est. Valuation
$32.25M
Total Funding Raised
$226.59M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cytovale is a biotechnology company that develops innovative diagnostic technologies using cell mechanics and machine learning to enable the early detection of sepsis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytovale Comparables
Compare Cytovale with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prenosis | 81% | |
| Inflammatix | 81% | |
| ASEP Medical Holdings Inc. | 78% | |
Cytovale Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Oct 10, 2024 | ||||
| Series C | Nov 15, 2023 | ||||
| Grant | Feb 8, 2022 | ||||
| Grant | May 19, 2020 | ||||
| Series B Extension | Oct 30, 2019 | ||||
Grant | Sep 28, 2019 |
Key People
Founding team and executive leadership
Cytovale Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pactolus Ventures | Series B, Series B Extension |
| CPP Investments | Series D |
| Dolby Family Ventures | Seed, Series A |
| IT-Farm Corporation | Series A |
| Thiel Foundation | Seed, Series A |
| Creative Ventures | Grant |
| Baidu Ventures | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Eric Khairy appointed as the new Chief Marketing Officer.
- Mar 1, 2025
Dave Vort appointed as Chief Commercial Officer.
Cytovale Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cytovale's valuation, stock price, and market status.